If the reported two-dose Pfizer pediatric COVID vaccine data to date for two to four-year-olds did not produce a strong enough immune response, do they have more data to support their application for FDA approval?

Medical Mythbusting Commentary for February 1, 2022


Pfizer is expected to ask the F.D.A. to authorize its Covid vaccine for children under 5.